AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Meglipride M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

LifeCare Formulation Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Meglipride M 2mg/500mg Tablet

Combiflex DM 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Administer Combiflex DM with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle adjustments are crucial for diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify its symptoms – sweating, dizziness, headache, trembling – and how to treat it promptly. Regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to track blood cell counts and liver function.

Primary Ingredients of Meglipride M 2mg/500mg Tablet

No text provided to rephrase.

Uses of Meglipride M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Meglipride M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Meglipride M 2mg/500mg Tablet should be administered with a meal.

Common Side effects of Meglipride M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Meglipride M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Meglipride M 2mg/500mg Tablet should be administered with food.

How Meglipride M 2mg/500mg Tablet works:

Each Meglipride M 2mg/500mg tablet contains glimepiride (a sulfonylurea) and metformin (a biguanide), two antidiabetic agents. Glimepiride stimulates pancreatic insulin release to reduce blood sugar, while metformin acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Meglipride M 2mg/500mg Tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Meglipride M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

The use of Meglipride M 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Meglipride M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Meglipride M 2mg/500mg tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Meglipride M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, initiation should involve a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Meglipride M 2mg/500mg Tablet :

Should you forget a Meglipride M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Meglipride M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Meglipride M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Meglipride M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Meglipride M 2mg/500mg tablets combine glimepiride and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Meglipride M 2mg/500mg Tablets may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Meglipride M 2mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Meglipride M 2mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Meglipride M 2mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Meglipride M 2mg/500mg Ta...
60
MRP 69
13% off